annb0t
Top 20
CSL to access late-stage next-generation mRNA platform technology, enabling development of vaccines for COVID-19, influenza, multi-pathogen pandemic preparedness and other respiratory pathogens
KING OF PRUSSIA, Pa., Dec. 12, 2022 /PRNewswire/ --Â CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that its subsidiary, CSL Seqirus, finalized its global collaboration and license agreement with Arcturus Therapeutics Holdings Inc ("Arcturus Therapeutics"; NASDAQ: ARCT). The agreement grants access...
>>> Read more: CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
KING OF PRUSSIA, Pa., Dec. 12, 2022 /PRNewswire/ --Â CSL Limited (ASX:CSL; USOTC:CSLLY) today announced that its subsidiary, CSL Seqirus, finalized its global collaboration and license agreement with Arcturus Therapeutics Holdings Inc ("Arcturus Therapeutics"; NASDAQ: ARCT). The agreement grants access...
>>> Read more: CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics
